Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses

Area of Science:

• Immunology
• Biotechnology
• Materials Science

Background:

• Protein-based vaccines show potential for cancer immunotherapy but suffer from poor cellular uptake, limiting immune responses.
• Nanoparticle-based delivery systems offer improved cellular uptake for antigens.
• This study explores nanogels as carriers for antigenic peptides in cancer immunotherapy.

Purpose of the Study:

• To synthesize and characterize cationic nanogels loaded with synthetic long peptides (SLPs) for cancer immunotherapy.
• To evaluate the efficacy of these nanogel formulations in stimulating immune responses in vitro and in vivo.
• To compare the immune response generated by covalently loaded peptides versus physically loaded peptides.

Main Methods:

• Covalent conjugation of SLPs containing CTL and CD4+ T-helper epitopes to cationic dextran nanogels via disulfide bonds.
• Characterization of nanogel size, zeta potential, and peptide loading content.
• In vitro assessment of dendritic cell maturation and T cell activation.
• In vivo evaluation of therapeutic efficacy in a cancer model.

Main Results:

• Cationic nanogels (210 nm, +24 mV) achieved high peptide loading (15%) and triggered peptide release under reducing conditions.
• Nanogels effectively matured dendritic cells (DCs) in vitro.
• Covalently SLP-loaded nanogels adjuvanted with poly(I:C) induced superior CD8+ T cell responses compared to soluble peptides and physically loaded formulations, both in vitro and in vivo.

Conclusions:

• Covalently loading synthetic long peptides into cationic nanogels is an effective strategy for cancer immunotherapy.
• This nanogel system demonstrates superior immune stimulation compared to conventional peptide delivery methods.
• Cationic nanogels represent a promising platform for developing therapeutic cancer vaccines.